Pcas Stock

Pcas Equity

Delisted·Dec 6, 2023

The The Equity of Pcas (PCA.PA) as of Aug 19, 2026 is -17.73 M EUR. In the previous year, The Equity was 27.82 M EUR — a change of -163.72% (lower).

Equity

-17.73 MEUR

YoY

-163.72%

Last updated:

In 2026, Pcas's equity was -17.73 M EUR, a -163.72% increase from the 27.82 M EUR equity in the previous year.

Access this data via the Eulerpool API

Pcas Stock analysis

What does Pcas do? Pcas SA is a French chemical company specializing in the development and production of chemical substances. It was founded in 1962 by a group of independent chemical engineers. The company has expanded its business areas over the years and now has four divisions: Materials Division, Fine Chemicals Division, Life Science Division, and Petrochemicals Division. The Materials Division focuses on manufacturing organic and inorganic materials such as polymers and specialty chemicals used in various industries including automotive and construction. The Fine Chemicals Division specializes in synthesizing pharmaceutical active ingredients used in medication production and new therapy development. Pcas SA offers a wide range of chemical compounds customized to customer needs. The Life Science Division is involved in the development and production of cell-based products used in diagnostics and pharmaceutical research. This division produces enzymes, specialized cells, proteins, and reagents. The Petrochemicals Division produces specialized polymer additives and tank cleaners used in petrochemical, refinery, and maritime industries. All divisions of Pcas SA prioritize customer satisfaction and quality assurance by implementing environmental and sustainability standards. The company is known for its ability to quickly and flexibly respond to customer needs and requirements, including production adjustments and the development of new products. Pcas SA invests in research and development, collaborating with leading research institutions and scientists to continuously improve and apply cutting-edge technologies. In addition to the mentioned divisions, Pcas SA also produces a wide range of chemical intermediates and specialty chemicals used in various industries such as cosmetics, food, photovoltaic, and electronics. Overall, Pcas SA is an innovative and versatile company known for its flexibility, quality assurance, and customer focus. It has earned a leading position in the international chemical industry through its high-quality products and services, as well as its commitment to sustainability and environmental protection. Pcas is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Pcas's Equity

Pcas's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Pcas's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Pcas's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Pcas's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Pcas’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Pcas stock

The Equity of Pcas is -17.73 M EUR in 2026.

The Equity of Pcas changed from 27.82 M EUR to -17.73 M EUR, representing a -163.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Pcas since 2006 – with annual values, charts, and detailed analysis.

The Equity's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Pcas historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Pcas

All Key Metrics — Pcas